Acarbose competitively inhibits pancreatic alpha-amylase and alpha-glucosidases found in the small intestine. This delays the digestion of complex carbohydrates and disaccharides to glucose and other monosaccharides. Glucose is absorbed lower in the GI tract in lesser amounts than is normal thereby reducing insulin re quirements during the postprandial hyperglycemic phase. Acarbose has no effect on lactase.
May be useful for mild reductions in blood glucose concentrations (250 – 350 mg/dl range) in dogs and cats with non-insulin-dependent diabetes mellitus and as adjunctive treatment of insulin dependent diabetes mellitus.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
只有在獸醫師確認確切人用單方錠劑、每錠含量與賦形劑、犬或貓、糖尿病狀態與非酮酸中毒、餐食與碳水化合物模式、目前胰島素／其他降血糖治療、腸胃肝腎風險，以及病患專屬血糖監測與低血糖處置計畫後，才可建立處方；不得用 D0739 通用列直接計算或自動調降胰島素。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
renal